DI BENEDETTO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 7.339
EU - Europa 6.366
AS - Asia 3.946
SA - Sud America 1.586
AF - Africa 142
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 19.393
Nazione #
US - Stati Uniti d'America 7.221
SG - Singapore 1.760
BR - Brasile 1.406
IE - Irlanda 1.222
CN - Cina 1.149
IT - Italia 1.134
SE - Svezia 1.090
RU - Federazione Russa 616
DE - Germania 598
HK - Hong Kong 477
UA - Ucraina 464
FR - Francia 366
FI - Finlandia 262
GB - Regno Unito 224
VN - Vietnam 168
PL - Polonia 164
IN - India 72
AR - Argentina 58
MX - Messico 48
CA - Canada 47
BE - Belgio 46
NL - Olanda 44
TR - Turchia 42
EC - Ecuador 40
IQ - Iraq 40
BD - Bangladesh 37
EG - Egitto 37
ZA - Sudafrica 32
AT - Austria 27
JP - Giappone 26
ES - Italia 25
MA - Marocco 25
CZ - Repubblica Ceca 21
UZ - Uzbekistan 19
IR - Iran 18
ID - Indonesia 16
CO - Colombia 15
PK - Pakistan 15
VE - Venezuela 15
UY - Uruguay 14
AZ - Azerbaigian 12
DZ - Algeria 12
KE - Kenya 11
LT - Lituania 11
CH - Svizzera 10
IL - Israele 10
PE - Perù 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
JO - Giordania 9
KG - Kirghizistan 8
LB - Libano 8
BO - Bolivia 7
CI - Costa d'Avorio 7
TN - Tunisia 7
CL - Cile 6
EU - Europa 6
KZ - Kazakistan 6
NP - Nepal 6
RO - Romania 6
SN - Senegal 6
BG - Bulgaria 5
GE - Georgia 5
GY - Guiana 5
LV - Lettonia 5
SA - Arabia Saudita 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
GR - Grecia 4
HU - Ungheria 4
PA - Panama 4
PH - Filippine 4
AL - Albania 3
EE - Estonia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KR - Corea 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
Totale 19.382
Città #
Dublin 1.222
Chandler 977
Singapore 911
Jacksonville 891
Dallas 818
Ashburn 802
Nyköping 549
Beijing 529
Hong Kong 475
Princeton 213
Boardman 198
Cambridge 196
Los Angeles 183
Dearborn 175
Messina 171
Des Moines 162
Medford 156
Warsaw 151
Moscow 149
Ann Arbor 147
The Dalles 131
Munich 126
São Paulo 116
Buffalo 97
Bremen 73
New York 71
Jinan 67
Wilmington 63
Shenyang 58
Milan 57
Florence 55
Woodbridge 55
Redondo Beach 54
Ho Chi Minh City 52
Turku 51
Tianjin 49
Brussels 45
Lancaster 44
Rome 42
San Mateo 41
Belo Horizonte 37
Catania 34
Frankfurt am Main 34
Düsseldorf 33
Rio de Janeiro 33
Hanoi 32
Cairo 31
Nanjing 28
Seattle 27
Haikou 26
Pune 26
Zhengzhou 26
Curitiba 25
Hebei 25
Santa Clara 25
Naples 23
Tokyo 23
Brasília 22
Houston 21
Brooklyn 20
Porto Alegre 20
Johannesburg 19
London 19
Ningbo 19
Salvador 19
Baghdad 18
Council Bluffs 18
Hangzhou 18
Helsinki 18
Montreal 18
Stockholm 18
Washington 17
Olomouc 16
Tashkent 16
Chicago 15
Guangzhou 15
Guayaquil 15
Quito 15
Vienna 15
Boston 14
Chennai 14
Guarulhos 14
Orem 14
Recife 14
Taizhou 14
Atlanta 13
Bologna 13
Campinas 13
Goiânia 13
Hyderabad 13
Baku 12
Denver 12
Mexico City 12
Montevideo 12
Norwalk 12
Nuremberg 12
Ribeirão Preto 12
San Francisco 12
Ankara 11
Dong Ket 11
Totale 11.568
Nome #
VALUTAZIONE DEI LIVELLI DI LIPOPROTEINA(A) ED INSULINA DURANTE E DOPO LA GRAVIDANZA. DATI PRELIMINARI 785
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 179
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 178
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 174
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 168
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 165
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 159
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 159
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 158
Italian risk factor-based screening for gestational diabetes. 153
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 149
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 148
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 146
Different concentration of human cord blood HMGB1 according to delivery and labour: A pilot study 145
Effects of myo-inositol on glucose variability in women with gestational diabetes 143
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 142
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 140
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 140
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 140
Myo-inositol may prevent gestational diabetes in PCOS women 139
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 139
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 135
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 134
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 134
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 131
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 127
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 127
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 126
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 122
Erectile dysfunction in compensated liver cirrhosis 122
C-reactive protein as an early predictor of gestational diabetes mellitus 120
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 119
Age and metabolic control influence lens opacity in IDDM patients 119
Epatite C: un fattore di rischio per il diabete? 118
Carotid atherosclerosis and lipid profile in a diabetic population: a retrospective evaluation 117
Anti-p53 autoantibodies in patients with IDDM 116
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 116
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 115
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 114
Correlates of total homocysteine plasma concentration in type 2 diabetes 114
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 114
Nuove evidenze sul ruolo della supplementazione con inositolo nel diabete gestazionale 114
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 113
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 111
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 111
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 111
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 110
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 110
Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network 110
Epatite C: un fattore di rischio per il diabete? 109
Serum thyroid hormone autoantibodies in type 1 diabetes mellitus 109
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 107
The complex interplay between clinical and person-centered diabetes outcomes in the two genders 107
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 106
Is diabetes mellitus a risk factor for HCV infection? 105
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 104
CAROTID ATHEROSCLEROSIS AND LIPID PROFILE IN A DIABETIC POPULATION: A RETROSPECTIVE EVALUATION 104
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 104
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 103
A multicenter Italian study on pregnancy outcome in women with diabetes 102
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 102
High mobility group protein B1: a new biomarker of obesity in pregnant women? 102
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 102
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 101
Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo Study 101
Hypoplastic nails and brachydactyly in a girl with moderate acne and hirsutism 101
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 100
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 100
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 99
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 99
Studio eco-strain degli effetti del trattamento con Genisteina sul ventricolo sinistro in donne in post-menopausa con sindome metabolica (Strain-Echo Assessment of Left Ventricular Effects of Genistein Treatment in Post-Menopausal Women with Metabolic Syndrome). 99
C-reactive protein as an early predictor of gestational diabetes mellitus. 98
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 97
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 97
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 96
La disfunzione diastolica nel diabete gestazionale 96
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 95
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 95
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 95
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 94
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 94
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 94
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 94
RUOLO DELL'IPEROMOCISTEINEMIA E DEL GENOTIPO C677T DEL GENE DELLA METILENE TEDRAIDROFOLATO REDUTTASI (MTHFR)IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 CON E SENZA SINDROME METABOLICA 93
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 93
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 93
Valutazione urodinamica computerizzata in diabeti di tipo 2: dati preliminari 92
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 92
Serum anti-p53 autoantibodies in patients with type 1 diabetes 91
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 91
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 91
Relationship between serum erythropoietin levels and rT3, T4 concentrations in elderly patients with non-thyroidal illnesses 90
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 90
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 89
A computerized network of diabetes clinics as a tool for quality of care improvement: the experience of Club Diabete Sicili@ 89
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 89
Taurine and osmoregulation: Platelet taurine content, uptake, and release in type 2 diabetic patients 88
EFFETTI DI UN BREVE PERIODO DI NORMALIZZAZIONE GLICEMICA SULLA FUNZIONE VENTRICOLARE SINISTRA IN DIABETICI INSULINO-DIPENDENTI. 87
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 87
BETA-CELL FUNCTION, PERIPHERAL SENSITIVITY TO INSULIN AND ISLET CELL AUTOIMMUNITY IN CYSTIC-FIBROSIS PATIENTS WITH NORMAL GLUCOSE-TOLERANCE 86
Totale 12.121
Categoria #
all - tutte 72.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021768 0 0 0 0 0 163 51 143 61 152 130 68
2021/20221.428 22 191 26 48 48 25 114 67 29 286 164 408
2022/20233.791 277 298 179 299 359 398 27 213 1.560 21 116 44
2023/2024991 80 157 65 124 74 160 35 58 0 40 6 192
2024/20254.262 58 60 96 259 193 162 80 875 1.076 257 437 709
2025/20264.601 602 818 819 738 909 715 0 0 0 0 0 0
Totale 19.640